Evidence map›Paper›PMID 31965671›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Enantioselective Total Synthesis of Macfarlandin C, a Spongian Diterpenoid Harboring a Concave-Substituted cis-Dioxabicyclo[3.3.0]octanone Fragment.

Tyler K Allred, André P Dieskau, Peng Zhao, Gregory L Lackner, Larry E Overman

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tyler K AllredDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.ORCID 0000-0002-7293-0413
André P DieskauDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.ORCID 0000-0003-3330-2614
Peng ZhaoDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.
Gregory L LacknerDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.ORCID 0000-0003-1085-5849
Larry E OvermanDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.ORCID 0000-0001-9462-0195

Funding

New Methods for the Synthesis of Neurological Agents and Other Heterocyclic MolecR01GM098601 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI OVERMAN, LARRY E. · 2011 to 2014
$1.6M
NIGMS NIH HHS R01 GM098601NIGMS NIH HHS R01-GM098601
6 · The paper itself

Abstract

The enantioselective total synthesis of the rearranged spongian diterpenoid (-)-macfarlandin C is reported. This is the first synthesis of a rearranged spongian diterpenoid in which the bulky hydrocarbon fragment is joined via a quaternary carbon to the highly hindered concave face of the cis-2,8-dioxabicyclo[3.3.0]octan-3-one moiety. The strategy involves a late-stage fragment coupling between a tertiary carbon radical and an electrophilic butenolide resulting in the stereoselective formation of vicinal quaternary and tertiary stereocenters. A stereoselective Mukaiyama hydration that orients a pendant carboxymethyl side chain cis to the bulky octahydronapthalene substituent was pivotal in fashioning the challenging concave-substituted cis-dioxabicyclo[3.3.0]octanone fragment.

Indexed as

Bridged Bicyclo Compounds, HeterocyclicChemistry Techniques, SyntheticElectron TransportStereoisomerismBridged Bicyclo Compounds, Heterocyclicdioxabicyclo(3.2.1)octaneC−C couplingnatural product synthesisphotoredox chemistryradical chemistryterpene synthesis

Identifiers

PMID31965671
PMCPMC8697475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.